Unilateral dysphotopsia after bilateral intraocular lens implantation using the AR40e IOL model: case report.
The authors report a recent complication during the postoperative period of cataract surgery. A patient was submitted to cataract surgery in both eyes with IOL implantation (Sensar) inside the capsular bag. The postoperative period of right eye was uneventful, however, in the left eye the patient noted a dark shadow at the temporal visual field at the first postoperative week. This diagnosis was confirmed with the presence of a temporal scotoma revealed by the computerized visual field (first reported in this study) and also reducing the pupil area with miotic drops. The treatment of this complication was performed by using brimonidine tartrate and after 6 months this symptom completely disappeared as confirmed by the computerized visual field. The treatment should be based on reducing the pupil area with miotic drops and we also recommend to observe these cases until the 6th postoperative month before indicating an IOL exchange since the capsular edge that overlaps the IOL may opacify creating an optical barrier reducing or eliminating negative dysphotopsia.
Marques
Frederico França
FF
Setor de Catarata, Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, SP, Brasil. fredani2010@terra.com.br
Marques
Daniela Meira Villano
DM
D000180:Acrylic Resins; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D002387:Cataract Extraction; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000009:adverse effects* / Q000295:instrumentation; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D008916:Miotics / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011474:Prosthesis Design; D011810:Quinoxalines / Q000627:therapeutic use; D012607:Scotoma / Q000175:diagnosis / Q000188:drug therapy; D014786:Vision Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014792:Visual Acuity; D058609:Visual Field Tests / Q000379:methods
D000180:Acrylic Resins; D000959:Antihypertensive Agents; D008916:Miotics; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate